Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Buy
53
AVDL Quote, Financials, Valuation and Earnings
Last price:
$10.82
Seasonality move
:
-1.07%
Day range:
$10.70 - $11.09
52-week range:
$6.38 - $17.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.36x
P/B ratio:
14.13x
Volume:
1.2M
Avg. volume:
1.5M
1-year change:
-32.06%
Market cap:
$1B
Revenue:
$169.1M
EPS (TTM):
-$0.27
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals PLC
|
$61.4M | $0.03 | 48.09% | -76.67% | $17.25 |
|
ALKS
Alkermes PLC
|
$341.4M | $0.38 | -14.01% | -21.1% | $41.19 |
|
AMRN
Amarin Corp PLC
|
$53.4M | -$0.61 | -20.31% | -- | $10.50 |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$1B | -$6.26 | 4.15% | 45.93% | $185.73 |
|
MDT
Medtronic PLC
|
$8.8B | $1.58 | 5.7% | 53.51% | $97.21 |
|
PRGO
Perrigo Co PLC
|
$1.1B | $0.59 | 1.58% | 5557.8% | $36.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals PLC
|
$10.83 | $17.25 | $1B | -- | $0.00 | 0% | 5.36x |
|
ALKS
Alkermes PLC
|
$29.22 | $41.19 | $4.8B | 13.98x | $0.00 | 0% | 3.25x |
|
AMRN
Amarin Corp PLC
|
$15.82 | $10.50 | $327.6M | -- | $0.00 | 0% | 1.53x |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$112.87 | $185.73 | $6.8B | 15.05x | $0.00 | 0% | 1.77x |
|
MDT
Medtronic PLC
|
$89.61 | $97.21 | $114.8B | 24.75x | $0.71 | 3.14% | 3.45x |
|
PRGO
Perrigo Co PLC
|
$26.96 | $36.50 | $3.7B | -- | $0.29 | 4.2% | 0.86x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals PLC
|
-- | -1.622 | -- | 2.12x |
|
ALKS
Alkermes PLC
|
-- | 0.948 | -- | 2.72x |
|
AMRN
Amarin Corp PLC
|
-- | 1.987 | -- | 2.39x |
|
JAZZ
Jazz Pharmaceuticals PLC
|
56.25% | 0.495 | 70.16% | 2.64x |
|
MDT
Medtronic PLC
|
37.21% | 0.556 | 26.13% | 1.20x |
|
PRGO
Perrigo Co PLC
|
45.39% | 0.740 | 94.29% | 1.05x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals PLC
|
$46.9M | -$3M | -35.57% | -35.57% | -4.96% | -$8.2M |
|
ALKS
Alkermes PLC
|
$257.3M | $13.8M | 22.98% | 25.91% | 8.32% | $88.7M |
|
AMRN
Amarin Corp PLC
|
$25.1M | -$16.8M | -16.98% | -16.98% | -39.88% | -$12.5M |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$793.2M | -$55.9M | 4.93% | 12.12% | -6.25% | $390.9M |
|
MDT
Medtronic PLC
|
$5.8B | $1.8B | 6.11% | 9.51% | 16.08% | $2.1B |
|
PRGO
Perrigo Co PLC
|
$392.3M | $79.4M | -2.12% | -4.01% | 4.53% | -$90M |
Avadel Pharmaceuticals PLC vs. Competitors
-
Which has Higher Returns AVDL or ALKS?
Alkermes PLC has a net margin of -9.37% compared to Avadel Pharmaceuticals PLC's net margin of 7.33%. Avadel Pharmaceuticals PLC's return on equity of -35.57% beat Alkermes PLC's return on equity of 25.91%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals PLC89.38% -$0.05 $74.1M ALKSAlkermes PLC83.95% $0.13 $1.5B -
What do Analysts Say About AVDL or ALKS?
Avadel Pharmaceuticals PLC has a consensus price target of $17.25, signalling upside risk potential of 59.28%. On the other hand Alkermes PLC has an analysts' consensus of $41.19 which suggests that it could grow by 40.96%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Alkermes PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Alkermes PLC.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals PLC5 0 0 ALKSAlkermes PLC10 5 0 -
Is AVDL or ALKS More Risky?
Avadel Pharmaceuticals PLC has a beta of 1.419, which suggesting that the stock is 41.933% more volatile than S&P 500. In comparison Alkermes PLC has a beta of 0.407, suggesting its less volatile than the S&P 500 by 59.265%.
-
Which is a Better Dividend Stock AVDL or ALKS?
Avadel Pharmaceuticals PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alkermes PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avadel Pharmaceuticals PLC pays -- of its earnings as a dividend. Alkermes PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or ALKS?
Avadel Pharmaceuticals PLC quarterly revenues are $52.5M, which are smaller than Alkermes PLC quarterly revenues of $306.5M. Avadel Pharmaceuticals PLC's net income of -$4.9M is lower than Alkermes PLC's net income of $22.5M. Notably, Avadel Pharmaceuticals PLC's price-to-earnings ratio is -- while Alkermes PLC's PE ratio is 13.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals PLC is 5.36x versus 3.25x for Alkermes PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals PLC5.36x -- $52.5M -$4.9M ALKSAlkermes PLC3.25x 13.98x $306.5M $22.5M
-
Which has Higher Returns AVDL or AMRN?
Amarin Corp PLC has a net margin of -9.37% compared to Avadel Pharmaceuticals PLC's net margin of -37.36%. Avadel Pharmaceuticals PLC's return on equity of -35.57% beat Amarin Corp PLC's return on equity of -16.98%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals PLC89.38% -$0.05 $74.1M AMRNAmarin Corp PLC59.81% -$0.80 $473.7M -
What do Analysts Say About AVDL or AMRN?
Avadel Pharmaceuticals PLC has a consensus price target of $17.25, signalling upside risk potential of 59.28%. On the other hand Amarin Corp PLC has an analysts' consensus of $10.50 which suggests that it could fall by -33.63%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Amarin Corp PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Amarin Corp PLC.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals PLC5 0 0 AMRNAmarin Corp PLC0 1 1 -
Is AVDL or AMRN More Risky?
Avadel Pharmaceuticals PLC has a beta of 1.419, which suggesting that the stock is 41.933% more volatile than S&P 500. In comparison Amarin Corp PLC has a beta of 0.823, suggesting its less volatile than the S&P 500 by 17.66%.
-
Which is a Better Dividend Stock AVDL or AMRN?
Avadel Pharmaceuticals PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amarin Corp PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avadel Pharmaceuticals PLC pays -- of its earnings as a dividend. Amarin Corp PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or AMRN?
Avadel Pharmaceuticals PLC quarterly revenues are $52.5M, which are larger than Amarin Corp PLC quarterly revenues of $42M. Avadel Pharmaceuticals PLC's net income of -$4.9M is higher than Amarin Corp PLC's net income of -$15.7M. Notably, Avadel Pharmaceuticals PLC's price-to-earnings ratio is -- while Amarin Corp PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals PLC is 5.36x versus 1.53x for Amarin Corp PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals PLC5.36x -- $52.5M -$4.9M AMRNAmarin Corp PLC1.53x -- $42M -$15.7M
-
Which has Higher Returns AVDL or JAZZ?
Jazz Pharmaceuticals PLC has a net margin of -9.37% compared to Avadel Pharmaceuticals PLC's net margin of -10.31%. Avadel Pharmaceuticals PLC's return on equity of -35.57% beat Jazz Pharmaceuticals PLC's return on equity of 12.12%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals PLC89.38% -$0.05 $74.1M JAZZJazz Pharmaceuticals PLC88.35% -$1.52 $9.5B -
What do Analysts Say About AVDL or JAZZ?
Avadel Pharmaceuticals PLC has a consensus price target of $17.25, signalling upside risk potential of 59.28%. On the other hand Jazz Pharmaceuticals PLC has an analysts' consensus of $185.73 which suggests that it could grow by 64.56%. Given that Jazz Pharmaceuticals PLC has higher upside potential than Avadel Pharmaceuticals PLC, analysts believe Jazz Pharmaceuticals PLC is more attractive than Avadel Pharmaceuticals PLC.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals PLC5 0 0 JAZZJazz Pharmaceuticals PLC13 1 0 -
Is AVDL or JAZZ More Risky?
Avadel Pharmaceuticals PLC has a beta of 1.419, which suggesting that the stock is 41.933% more volatile than S&P 500. In comparison Jazz Pharmaceuticals PLC has a beta of 0.321, suggesting its less volatile than the S&P 500 by 67.888%.
-
Which is a Better Dividend Stock AVDL or JAZZ?
Avadel Pharmaceuticals PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Jazz Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avadel Pharmaceuticals PLC pays -- of its earnings as a dividend. Jazz Pharmaceuticals PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or JAZZ?
Avadel Pharmaceuticals PLC quarterly revenues are $52.5M, which are smaller than Jazz Pharmaceuticals PLC quarterly revenues of $897.8M. Avadel Pharmaceuticals PLC's net income of -$4.9M is higher than Jazz Pharmaceuticals PLC's net income of -$92.5M. Notably, Avadel Pharmaceuticals PLC's price-to-earnings ratio is -- while Jazz Pharmaceuticals PLC's PE ratio is 15.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals PLC is 5.36x versus 1.77x for Jazz Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals PLC5.36x -- $52.5M -$4.9M JAZZJazz Pharmaceuticals PLC1.77x 15.05x $897.8M -$92.5M
-
Which has Higher Returns AVDL or MDT?
Medtronic PLC has a net margin of -9.37% compared to Avadel Pharmaceuticals PLC's net margin of 11.83%. Avadel Pharmaceuticals PLC's return on equity of -35.57% beat Medtronic PLC's return on equity of 9.51%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals PLC89.38% -$0.05 $74.1M MDTMedtronic PLC64.75% $0.82 $76.7B -
What do Analysts Say About AVDL or MDT?
Avadel Pharmaceuticals PLC has a consensus price target of $17.25, signalling upside risk potential of 59.28%. On the other hand Medtronic PLC has an analysts' consensus of $97.21 which suggests that it could grow by 8.48%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Medtronic PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Medtronic PLC.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals PLC5 0 0 MDTMedtronic PLC13 13 0 -
Is AVDL or MDT More Risky?
Avadel Pharmaceuticals PLC has a beta of 1.419, which suggesting that the stock is 41.933% more volatile than S&P 500. In comparison Medtronic PLC has a beta of 0.804, suggesting its less volatile than the S&P 500 by 19.64%.
-
Which is a Better Dividend Stock AVDL or MDT?
Avadel Pharmaceuticals PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Medtronic PLC offers a yield of 3.14% to investors and pays a quarterly dividend of $0.71 per share. Avadel Pharmaceuticals PLC pays -- of its earnings as a dividend. Medtronic PLC pays out 76.98% of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AVDL or MDT?
Avadel Pharmaceuticals PLC quarterly revenues are $52.5M, which are smaller than Medtronic PLC quarterly revenues of $8.9B. Avadel Pharmaceuticals PLC's net income of -$4.9M is lower than Medtronic PLC's net income of $1.1B. Notably, Avadel Pharmaceuticals PLC's price-to-earnings ratio is -- while Medtronic PLC's PE ratio is 24.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals PLC is 5.36x versus 3.45x for Medtronic PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals PLC5.36x -- $52.5M -$4.9M MDTMedtronic PLC3.45x 24.75x $8.9B $1.1B
-
Which has Higher Returns AVDL or PRGO?
Perrigo Co PLC has a net margin of -9.37% compared to Avadel Pharmaceuticals PLC's net margin of -0.61%. Avadel Pharmaceuticals PLC's return on equity of -35.57% beat Perrigo Co PLC's return on equity of -4.01%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals PLC89.38% -$0.05 $74.1M PRGOPerrigo Co PLC37.58% -$0.05 $8B -
What do Analysts Say About AVDL or PRGO?
Avadel Pharmaceuticals PLC has a consensus price target of $17.25, signalling upside risk potential of 59.28%. On the other hand Perrigo Co PLC has an analysts' consensus of $36.50 which suggests that it could grow by 35.39%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Perrigo Co PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Perrigo Co PLC.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals PLC5 0 0 PRGOPerrigo Co PLC1 2 0 -
Is AVDL or PRGO More Risky?
Avadel Pharmaceuticals PLC has a beta of 1.419, which suggesting that the stock is 41.933% more volatile than S&P 500. In comparison Perrigo Co PLC has a beta of 0.451, suggesting its less volatile than the S&P 500 by 54.881%.
-
Which is a Better Dividend Stock AVDL or PRGO?
Avadel Pharmaceuticals PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perrigo Co PLC offers a yield of 4.2% to investors and pays a quarterly dividend of $0.29 per share. Avadel Pharmaceuticals PLC pays -- of its earnings as a dividend. Perrigo Co PLC pays out -88.77% of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or PRGO?
Avadel Pharmaceuticals PLC quarterly revenues are $52.5M, which are smaller than Perrigo Co PLC quarterly revenues of $1B. Avadel Pharmaceuticals PLC's net income of -$4.9M is higher than Perrigo Co PLC's net income of -$6.4M. Notably, Avadel Pharmaceuticals PLC's price-to-earnings ratio is -- while Perrigo Co PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals PLC is 5.36x versus 0.86x for Perrigo Co PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals PLC5.36x -- $52.5M -$4.9M PRGOPerrigo Co PLC0.86x -- $1B -$6.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
